HighPoint Advisor Group’s Fortress Biotech FBIO Stock Holding History

HighPoint Advisor Group’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-137	Closed	-$101K	–	504
2019 Q2	$101K	Sell	137 -1,369	-91%	-$35.2K	0.02%	461
2019 Q1	$258K	Sell	1,506 -789	-34%	-$20.7K	0.06%	268
2018 Q4	$316K	Buy	2,295 +19	+0.8%	+$317	0.08%	210
2018 Q3	$274K	Buy	2,276 +818	+56%	+$26.2K	0.08%	244
2018 Q2	$301K	Buy	1,458 +6	+0.4%	+$338	0.08%	230
2018 Q1	$393K	Sell	1,452 -765	-35%	-$48.4K	0.11%	198
2017 Q4	$416K	Buy	+2,217	New	+$131K	0.12%	183
2017 Q3	–	Sell	-815	Closed	-$51K	–	279
2017 Q2	$51K	Hold	815	–	–	0.02%	275
2017 Q1	$51K	Buy	+815	New	+$36.5K	0.02%	275
2016 Q4	–	Sell	-949	Closed	-$35K	–	281
2016 Q3	$35K	Hold	949	–	–	0.01%	277
2016 Q2	$42K	Buy	+949	New	+$44.2K	0.01%	270
2016 Q1	–	Sell	-949	Closed	-$37K	–	230
2015 Q4	$37K	Buy	+949	New	+$39.8K	0.02%	197

Other funds holding FBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OPPM

Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

HighPoint Advisor Group's FBIO Position: Q3 2019 in Review

HighPoint Advisor Group sold out of Fortress Biotech (FBIO) in Q3 2019, closing a stake of 137 shares — an estimated $101K sold.

HighPoint Advisor Group first reported a position in FBIO in Q4 2015 and held it in 12 quarters. The position peaked at $416K in Q4 2017. 49 funds tracked by Wall St. Rank hold FBIO as of Q3 2019.

HighPoint Advisor Group reported no remaining Fortress Biotech position as of Q3 2019 after selling out during the quarter.
HighPoint Advisor Group sold 137 Fortress Biotech shares in Q3 2019, an estimated $101K.
HighPoint Advisor Group first reported a position in Fortress Biotech in Q4 2015 and held it in 12 quarters.
HighPoint Advisor Group's Fortress Biotech position peaked at $416K in Q4 2017.
49 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2019.

Based on HighPoint Advisor Group's 13F filing for Q3 2019, filed 12 Nov 2019.